Blood transfusion in obstetrics and gynaecology

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 3, 1997, Pages 278-284

  Ekeroma, Alec J ^a   Ansari, Andrew ^a   Stirrat, Gordon M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; BLEEDING; BLOOD TRANSFUSION; CESAREAN SECTION; ERYTHROCYTE TRANSFUSION; FEMALE; GYNECOLOGY; HUMAN; OBSTETRICS; PREGNANCY DISORDER; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; CESAREAN SECTION; FEMALE; HIV INFECTIONS; HUMANS; HYSTERECTOMY; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PRENATAL CARE;

EID: 0031058013     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb11454.x     Document Type: Review

References (57)

1. Camman WR, Datta S. Red cell use during caesarean delivery. Transfusion 1991; 31:12–15.
2. Cooley JR, Kitay DZ. Haematologic problems in pregnancy v. obstetric transfusion therapy. Am J Obstet Gynecol 1977; 128:476–479.
3. Benjamin I, Barakat RR, Curtin JP, Jones WB et al. Blood transfusion for radical hysterectomy before and after the discovery of transfusion-related HIV. Obstet Gynecol 1994; 84:974–978.
4. Morrison J, Sumrill D, Chevalier SP et al. The effect of provider education on blood utilisation practices. Am J Obstet Gynecol 1993; 169: 1240–1245.
5. Sandier SG, Beyth Y, Laufer N, Levene C. Autologous blood transfusion and pregnancy. Obstet Gynecol 1979; 53: 62–66.
6. Kamani AA, McMorland GH, Wadsworth LD. Utilisation of red blood cell transfusion in an obstetric setting. Am J Obstet Gynecol 1988; 159:1177–1181.
7. Herbert WN, Owen HG, Collins ML. Autologous blood storage in obstetrics. Obstet Gynecoli 1988; 72: 166–170.
8. Druzin ML, Wolf CF, Edersheim TG et al. Donation of blood by the pregnant patient for autologous transfusion. Am J Obstet Gynecol 1988; 159: 1023–1027.
9. Roberts L, Andres MD, Kathleen M et al. A reappraisal of the need for autologous blood donation in the obstetric patient. Am J Obstet Gynecol 1990; 163: 1551–1553.
10. Kruskall MS, Leonard S, Klapholz H. Autologous blood donation during pregnancy: Analysis of safety and blood use. Obstet Gynaecol 1987; 70:938–941.
11. Combs CA, Murphy EL, Laros RK. Cost-benefit analysis of autologous blood donation in obstetrics. Obstet Gynecol 1992; 80: 621–625.
12. Silva PD, Beguin EA. Intraoperative rapid autologous blood transfusion. Am J Obstet Gynecol 1989; 160: 1226–1227.
13. Hill T, Lavin P. Blood ordering in Obstetrics and Gynaecology: Recommendations for the type and screen. Obstet Gynecol 1993; 62: 659–664.
14. Ness PM, Rosche ME, Barrasso C, Luff RD, Johnson JW. The efficacy of type and screen to reduce unnecessary cross matches for obstetric patients. Am J Obstet Gynecol 1981; 140: 661–664.
15. Contreras M, editor. ABC of transfusion. BMJ 1992.
16. Clark VA, Wardall GJ, McGrady EM. Blood ordering practices in obstetric units in the United Kingdom. Anaesthesia 1993; 48: 998–1001.
17. Klapholz H. Blood transfusion in contemporary obstetric practice. Obstet Gynecol 1990; 75:940–943.
18. Sherman SJ, Greenspoon JS, Nelson JM, Paul RH. Identifying the obstetric patient at high risk of multiple-unit blood transfusions. J Reprod Med 1992; 37: 649–652.
19. Nicholls MD, Whyte G. Red cell, plasma and albumin transfusion decision triggers. Anesthesia and Intensive Care 1993; 21: 156–162.
20. Sirchia G, Giovanetti AM, McClelland DBL, Fracchia ON, editors. Safe and Good Use of Blood in Surgery (SANGUIS). European Commission, 1994.
21. Maxwell CN. Blood Transfusion and caesarean section. Aus NZ J Obstet Gynaecol 1989; 29: 121–125.
22. Imberti R, Preseglio I, Trotta V et al. Blood Transfusion during caesarean section. A 12 years' retrospective analysis. Acta Anaesth Belgical 990;41:139–144.
23. Ross A, Malkoutzis E. Blood transfusion practice in obstetric and gynaecological anaesthesia. Anaesthesia and Intensive Care 1995; 23: 645.
24. Naef RW, Washburne JF, Martin RW, Magann EF et al. Haemorrhage associated with caesarean delivery: When is transfusion needed J Perinatal 1995; 15: 32–35.
25. Mintz PD, Sullivan MF. Preoperative crossmatch ordering and blood use in elective hysterectomy. Obstet Gynecol 1985; 65: 389–392.
26. Sarnra SK, Friedman BA, Beitler PJ. A study of blood utilisation in association with hysterectomy. Transfusion 1983; 23: 490–495.
27. Nolan TE, Gallup DG. Massive transfusion: A current review. Obstet Gynecol Surv 1991; 46: 289–295.
28. Indications for the use of red blood cells, platelets and fresh frozen plasma. US Report of Health and Human Services 1989, Washington DC.
29. Johnson, Turner, Kruskall, Sirois, Gervino. Comparison of two transfusion strategies after elective operations for myocardial revascularisation. J Cardiovasc ThorSurg 1992; 104: 307–314.
30. Rosen NR, Bates LH, Herod G. Transfusion therapy: Improved patient care and resource utilisation. Transfusion 1993; 33:341–347.
31. Indications for use of Red Blood Cells, Platelet and Fresh Frozen Plasma. Red Cross Blood Bank 1993. Victoria Australia.
32. Voak D. Guidelines for administration of blood products: Transfusion of infants and neonates. British Committee for Standards in Haematology Task Force. Transfusion Med 1994; 4:63–69.
33. Proceedings of the Red Cell Tranfusion Consensus Conference; 9–10 May 1994. Edinburgh : Royal College of Physicians of Edinburgh, 1994.
34. Atrah HI, Galea G, Urbaniak SJ. The sustained impact of a group and screen and maximum surgical blood ordering schedule policy on the transfusion practice in gynaecology and obstetrics. Clin Lab Haematol 1995; 17: 177–181.
35. Hibbard BM, Anderson MM, O'Drife J et al. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1991-1993. HMSO London 1996.
36. Wardrop CAJ, Holland BM, Gareth Jones J. Consensus on red cell transfusion. BMJ 1995; 311: 962–963.
37. Seely HF. Massive blood loss in obstetrics. In: Tumbull A, Chamberlain G, editors. Obstetrics, 1989. Churchill Livingstone: London : 877–887.
38. Martin C, Dildy GA. Blood component therapy. Contemp ObstetGvmzeeo/1994: 11–27.
39. Rabinowitz M, Gilibert JE, Lenes BA. Avoiding blood transfusion. A report of two cases. J Reprod Med 1990; 35: 569–572.
40. Evans LC, Combs CA. Increase maternal morbidity after caesarean section delivery before 28 weeks of gestation. Int J Obstet Gynecol 1993; 40:227–233.
41. Dickason LA, Dinsmoor MJ. Red blood cell transfusion and caesarean section. Am J Obstet Gynecol 1992; 167: 327–330.
42. Saxena S, Rabinowitz AP, Johnson C, Shulman IA. Iron-deficiency anaemia: A medically treatable chronic anaemia as a model of transfusion overuse. Am J Med 1993; 94: 120–124.
43. Koshy M, Burd L, Wallace D, Moawad A, Baron J. Prophylactic red cell transfusions in pregnant patients with sickle cell disease. A randomised cooperative study. N Engl J Med 1988; 319: 1447–1452.
44. Collier J, editor. The risks and uses of donated blood. Drug Therapeut Bull 1993; 31: 89–92.
45. Donahue JG, Munoz A, Ness PM, Brown DE Jr et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327:419–421.
46. Perkins H. Transfusion reactions: The changing priorities. Immun Invest 1995; 24: 289–302.
47. Morris JA Jr, Wilcox TR, Reed GW, Hunter EB et al. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion. Annal Surg 1994; 219: 517–525.
48. McGregor JA, Rubright G, Ogle JW. Congenital CMV infection as a preventable complication of maternal transfusion. J Reprod Med 1990; 35: 61–64.
49. Adler SP. Transfusion-associated CMV infection. Rev Infect Dis 1983; 5: 977–993.
50. Morduchowicz G, Pitlik SD, Huminer D, Alkan M et al. Transfusion reactions due to bacterial contamination of blood and blood products. Rev Infect Dis 1991; 13: 307–314.
51. Tartter PI. Immunologic effects of blood transfusion. Immun Invest 1995; 24:277–288.
52. McGehee RP, Dodson MK, Moore JL, Morrison FS et al. Effect of blood transfusion in patients with gynaccologic malignancy. Int J Obstet Gynecol 1994; 46:45–52.
53. Monk BJ, Tewari K, Gamboa-Vujicic G, Burger RA et al. Does perioperative blood transfusion affect survival in patients with cervical cancer treated with radical hysterectomy. Obstet Gynecol 1995; 85: 343–348.
54. Look KY, Reisinger M, Stehman FB, Miser M et al. Blood transfusion and the risk of recurrence in squamous carcinoma of the vulva. Am J Obstet Gynecol 1993; 168: 1718–1721.
55. King DJ. Transfusion and the use of blood products. Baillieres Clin Haematol 1991; 4: 545–569.
56. Morrison JC, Sumrall DD, Chevalier SP, Robinson SV et al. The effect of provider education on blood utilisation practices. Am J Obstet Gynecol 1993; 169: 1240–1245.
57. Vos J, Gumodoka B, van Asten HA, Berege ZA et al. Changes in blood transfusion practices after the introduction of consensus guidelines in Mwanza region, Tanzania. AIDS 1994; 8:1135–1140.